Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

S 749Session 2025-2026

What changed between versions

27 paragraphs changed+117 words added−21 removed

Highlighted text was added in the newer version. Struck-through text was removed.

South Carolina General Assembly 126th Session, 2025-2026

Bill 749

Download This Bill in Microsoft Word Format

Indicates Matter Stricken Indicates New Matter

(Text matches printed bills. Document has been reformatted to meet World Wide Web specifications.)

S. 749

STATUS INFORMATION

Joint Resolution Sponsors: Senator Ott Companion/Similar bill(s): 4768 Document Path: LC-0531WAB26.docx

Introduced in the Senate on January 13, 2026 Currently residing in the Senate Committee on Medical Affairs

HISTORY OF LEGISLATIVE ACTIONS

Date

Body

Action Description with journal page number

12/10/2025

Senate

Prefiled

12/10/2025

Senate

Referred to Committee on Medical Affairs

1/13/2026

Senate

Introduced and read first time (Senate Journal-page 41)

1/13/2026

Senate

Referred to Committee on Medical Affairs (Senate Journal-page 41)

View the latest legislative information at the website

VERSIONS OF THIS BILL

12/10/2025

A joint Resolution

33 unchanged paragraphs

TO CREATE THE "PRESCRIPTION MEDICINE STUDY COMMITTEE" TO EXAMINE AND RECOMMEND INNOVATIVE METHODS TO REDUCE COSTS FOR PRESCRIPTION MEDICINES CONSIDERED CRITICAL TO SOUTH CAROLINA CITIZENS; TO PROVIDE FOR THE MEMBERSHIP, DUTIES, AND RESPONSIBILITIES OF THE COMMITTEE; AND TO REQUIRE A REPORT OF FINDINGS AND RECOMMENDATIONS TO THE GENERAL ASSEMBLY.

Whereas, access to affordable prescription medicine is essential to the health, stability, and well-being of the citizens of South Carolina; and

Whereas, chronic diseases such as diabetes, heart disease, and dementia disproportionately affect South Carolina residents and require continuous access to life-sustaining medications; and

Whereas, the rising cost of prescription drugs places a significant financial burden on families, healthcare providers, and the State; and

Whereas, identifying innovative, transparent, and effective methods to reduce prescription medicine costs is in the best interest of the State and its citizens. Now, therefore,

Be it enacted by the General Assembly of the State of South Carolina:

SECTION 1. (A) There is created the Prescription Medicine Study Committee to evaluate methods and strategies to reduce costs of prescription medicines considered critical to the health, well-being, and longevity of the citizens of South Carolina.

(B)(1) The committee shall:

(a) identify and review innovative methods used in other states, the federal government, and private industry to reduce the cost of prescription medicines, with a primary focus on medications necessary for the treatment or management of diabetes, heart disease, dementia, and other diseases prevalent among South Carolina citizens.

(b) evaluate current cost barriers, including pricing structures, supply chains, and the role of pharmacy benefit managers, insurers, and pharmaceutical manufacturers.

(c) recommend policy proposals, statutory changes, pilot programs, or regulatory modifications that could result in lower prescription costs without compromising patient safety, access, or quality of care.

(d) consider opportunities for state-led initiatives, such as bulk purchasing, state-supported pharmaceutical distribution models, rebate reforms, manufacturer transparency requirements, or other mechanisms used in similar jurisdictions.

(e) engage South Carolina consumers, providers, and industry stakeholders through hearings, written submissions, or other information-gathering methods the committee finds beneficial.

(2) In fulfilling its duties, the committee may request data, reports, or assistance from any state agency.

(D)(1) The Prescription Medicine Study Committee shall be composed of the following members:

(a) the Chair of the House Labor, Commerce and Industry Committee, or his designee;

(b) the Chair of the Senate Banking and Insurance Committee, or his designee;

(c) the Chair of the House Medical, Military, Public and Municipal Affairs Committee, or his designee;

(d) the Chair of the Senate Medical Affairs Committee or his designee;

(e) the Director of the Department of Insurance or his designee;

(f) the Director of the Department of Public Health or his designee;

(g) the Executive Director of the South Carolina Public Employee Benefit Authority (PEBA) or his designee;

(h) the Director of the South Carolina Medical Association or his designee;

(i) the President of the Hospital Association or his designee;

(j) one representative of a health plan that does not own, control, or have a stake in a pharmacy benefit manager within the health plan's corporate structure, appointed by the Governor; and

(k) one representative of a pharmacy benefits management company, appointed by the Governor.

(2) The members shall elect a chair and vice chair from among themselves at the committee's first meeting.

(3) The committee shall meet as soon as practicable upon appointment of all members.

(4) A majority of members constitutes a quorum.

(5) Staff support shall be provided by the appropriate committees of the House of Representatives and the Senate, and by any relevant state agencies as reasonably requested.

(6) Members of the committee shall serve without compensation but may receive mileage, subsistence, and per diem as provided by state law for legislative committees.

(E) The committee shall prepare and submit a report of its findings and recommendations, including any proposed legislation, to the General Assembly no later than December 31, 2026. Upon submission of the report, the committee is dissolved unless reauthorized by joint resolution.

SECTION 2. This joint resolution takes effect upon approval by the Governor.

----XX----

This web page was last updated on DecemberJanuary 1013, 20252026 at 021:3109 PM

Back to the full text